Co ntinuous subcutaneous insulin infusion (CSII) improves nocturnal and morning glycaemic co ntrol compared with multiple daily injection (MDI) regimens. With multiple injection re g imens the morning injection must not be delaye d. Total and bolus insulin doses required are lower with CSII compared with MDI 130
---
 nice.evidencecategory: Ib
[@Haakens_1989]
